Kevin Greenslade

Characterization of the Structural Features and Interactions of Sclerostin

Václav Veverka, Alistair J. Henry, Patrick M. Slocombe et al. · Journal of Biological Chemistry · 2009 · 235 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Bryan Smith, Rocío Lledó‐García, Kate L. Dixon et al. · mAbs · 2018 · 110 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

Massimo Marenzana, Kevin Greenslade, Alison Eddleston et al. · Arthritis & Rheumatism · 2011 · 74 citations

Medicine, Endocrinology, Immunology +17

Effects of diacerhein on granuloma induced cartilage breakdown in the mouse

Adrian Moore, Kevin Greenslade, Chandan Alam et al. · Osteoarthritis and Cartilage · 1998 · 65 citations · Full text

Medicine, Immunology, Pathology +12

Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists

Gill Holdsworth, Kevin Greenslade, Joby K. Jose et al. · Bone · 2017 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17